 impact intensifi therapi clinic outcom infant children neuroblastoma St jude children research hospit experi impact intensifi therapi surviv infant year children equal year age neuroblastoma result success clinic trial variou combin antineoplast drug surgeri radiotherapi chang treatment surviv children noncontigu lymph node distant metastat diseas combin cisplatin teniposid basic regimen cyclophosphamid doxorubicin ctx/dox surviv SE previou treatment log-rank test surviv infant metastat diseas ctx/dox patient diseas resist former combin studi subset infant tumor marrow diagnosi therapeut approach probabl long-term surviv small group children year age local unresect tumor switch ctx/dox chemotherapi surviv multivari analysi young age limited-diseas stage nonadren primari site intensifi treatment independ predictor favor outcom substanti advanc treatment neuroblastoma past year institut current overal surviv probabl estim common solid tumor childhood